A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours. - Paridaens, R; Uges, D R A; Barbet, N; Choi, L; Seeghers, M; Graaf, W T A van der; Groen, H J M; Dumez, H; Buuren, I Van; Muskiet, F; Capdeville, R; Oosterom, A T van; et al. (British Journal of Cancer, 2000)